𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Lille Apathy Rating Scale: Validation of a caregiver-based version

✍ Scribed by Kathy Dujardin; Pascal Sockeel; Marie Delliaux; Alain Destée; Luc Defebvre


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
103 KB
Volume
23
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Apathy is reported in 16.5% to 70% of Parkinson's disease (PD) patients. Our recently developed Lille Apathy Rating Scale (LARS) has been specifically validated for patient‐based assessment of apathy in PD. The aim of the present study was to validate a caregiver‐based version of the LARS. Sixty consecutive PD patients and their respective caregivers participated in the study. An informant‐based version of the LARS (LARS‐i) was developed to rate apathy via a caregiver‐based structured interview. Apathy was also assessed in a patient‐based interview using the LARS and the informant‐ and clinician‐rated versions of the Apathy Evaluation Scale (AES). Cronbach's alpha and standardized alpha coefficients were 0.872 and 0.877, respectively, and the split‐half reliability was 0.901 (revealing good internal consistency). The test‐retest and inter‐rater reliability values were 0.960 and 0.996, respectively. Criterion‐related validity (according to an independent, expert diagnosis) was good. Scores on the LARS and the LARS‐i were highly correlated. However, apathy was rated significantly more severely by the caregiver than by the patient. This difference was significantly higher for demented than nondemented PD patients. The LARS‐i was seen to have excellent psychometric properties and appears to be valid for use in PD with respect to the patient‐based LARS and the informant‐ and clinician‐rated versions of the AES. © 2008 Movement Disorder Society


📜 SIMILAR VOLUMES


Examination of the Lille Apathy Rating S
✍ Laura B. Zahodne; Shamar Young; Lindsey Kirsch-Darrow; Anne Nisenzon; Hubert H. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract Apathy is a unique, multidimensional syndrome commonly encountered in patients with Parkinson disease (PD). Recently, the Lille Apathy Rating Scale (LARS), a semistructured interview yielding a global score, and composite subscores for different domains of apathy (i.e., cognitive, behav

The validity of a caregiver-rated brief
✍ Peter V. Rabins 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 1 views

## Abstract The validity of a 12‐item brief behavioral symptom rating scale for use in the cognitively impaired was studied using nurse clinician ratings for criterion validity and the Brief Psychiatric Rating Scale and Behavioral Scale of the Psychogeriatric Dependency Rating Scale for convergent

Portuguese version of the Delirium Ratin
✍ Daniel Philippi de Negreiros; Alexandrina Maria Augusto da Silva Meleiro; Letíci 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

## Abstract ## Objective To assess the validity and the reliability of the Portuguese version of the Delirium Rating Scale‐Revised‐98 (DRS‐R‐98). ## Methods The scale was translated into Portuguese and back‐translated into English. After assessing its face validity, five diagnostic groups (__n__

Delirium subtype identification and the
✍ Sophia E. de Rooij; Barbara C. van Munster; Johanna C. Korevaar; Gerty Casteelen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract ## Background Delirium is the most common acute neuropsychiatric disorder in hospitalized elderly. The Dutch version of the Delirium Rating Scale—Revised‐98 (DRS‐R‐98) appears to be a reliable method to classify delirium. The aim of this study was to determine the validity and reliabil

A shortened version of the motor section
✍ S. Siesling; A. H. Zwinderman; J. P. P. van Vugt; K. Kieburtz; Prof. Dr. R. A. C 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 1 views

## Abstract Objective assessment of clinical findings of patients with Huntington's disease (HD) is necessary for an evaluation of the individual progression of the disease and the effect of therapy, and it requires specific assessment scales. The Unified Huntington's Disease Rating Scale (UHDRS) i